We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.6B
AUM Growth
+$255M
Cap. Flow
-$824M
Cap. Flow %
-2.45%
Top 10 Hldgs %
29.14%
Holding
1,152
New
97
Increased
418
Reduced
387
Closed
96

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$94.4M
2
ELV icon
Elevance Health
ELV
+$74.7M
3
PAYO icon
Payoneer
PAYO
+$71.5M
4
ABT icon
Abbott
ABT
+$64.2M
5
GE icon
GE Aerospace
GE
+$63.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$101M
2
AAPL icon
Apple
AAPL
+$98.8M
3
AMGN icon
Amgen
AMGN
+$85.8M
4
TXN icon
Texas Instruments
TXN
+$80.9M
5
BIIB icon
Biogen
BIIB
+$73M

Sector Composition

Rank Sector Weight
1 Technology 37.8%
2 Healthcare 15.65%
3 Consumer Discretionary 11.06%
4 Financials 8.19%
5 Industrials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INST
601
DELISTED
Instructure Holdings, Inc.
INST
$3.53M 0.01%
150,801
-73,951
-33% -$1.57M
URBN icon
602
Urban Outfitters
URBN
$6.5B
$3.51M 0.01%
85,535
-7,137
-8% -$293K
IBP icon
603
Installed Building Products
IBP
$5.31B
$3.51M 0.01%
17,058
-6,234
-27% -$1.4M
VRNT
604
DELISTED
Verint Systems
VRNT
$3.48M 0.01%
108,112
-15,679
-13% -$500K
NU icon
605
Nu Holdings
NU
$68.5B
$3.47M 0.01%
+269,550
New +$3.14M
GEV icon
606
GE Vernova
GEV
$235B
$3.47M 0.01%
+20,245
New +$3.21M
CCEP icon
607
Coca-Cola Europacific Partners
CCEP
$45.4B
$3.47M 0.01%
47,617
+3,504
+8% +$252K
BAP icon
608
Credicorp
BAP
$29.6B
$3.47M 0.01%
21,500
-2,620
-11% -$433K
LNW
609
DELISTED
Light & Wonder
LNW
$3.46M 0.01%
32,966
LAUR icon
610
Laureate Education
LAUR
$4.94B
$3.42M 0.01%
228,814
-128,523
-36% -$1.92M
VRSN icon
611
VeriSign
VRSN
$26.9B
$3.4M 0.01%
19,138
-5,075
-21% -$904K
BCO icon
612
Brink's
BCO
$4.48B
$3.38M 0.01%
33,038
GGB icon
613
Gerdau
GGB
$9.93B
$3.38M 0.01%
1,024,392
-133,537
-12% -$472K
BFAM icon
614
Bright Horizons
BFAM
$3.28B
$3.36M 0.01%
30,558
-1,069
-3% -$116K
ED icon
615
Consolidated Edison
ED
$38.9B
$3.33M 0.01%
37,282
+466
+1% +$43.2K
ENB icon
616
Enbridge
ENB
$106B
$3.33M 0.01%
93,650
+5,226
+6% +$187K
OSIS icon
617
OSI Systems
OSIS
$3.23B
$3.33M 0.01%
24,231
AZZ icon
618
AZZ Inc
AZZ
$4B
$3.33M 0.01%
43,133
ZM icon
619
Zoom
ZM
$27.2B
$3.3M 0.01%
55,688
-54,152
-49% -$3.33M
KYMR icon
620
Kymera Therapeutics
KYMR
$9.41B
$3.26M 0.01%
109,279
+62
+0.1% +$2.15K
VICI icon
621
VICI Properties
VICI
$27.3B
$3.24M 0.01%
113,210
+102,280
+936% +$2.94M
IMCR icon
622
Immunocore
IMCR
$1.64B
$3.22M 0.01%
95,012
+55
+0.1% +$2.81K
ZION icon
623
Zions Bancorporation
ZION
$9.92B
$3.21M 0.01%
74,030
-99,960
-57% -$4.22M
NSSC icon
624
Napco Security Technologies
NSSC
$1.29B
$3.19M 0.01%
61,498
ELF icon
625
e.l.f. Beauty
ELF
$5.63B
$3.16M 0.01%
15,011
-25,778
-63% -$4.58M

Similar funds

Axa's Q2 2024 Portfolio in Review

As of Q2 2024, Axa held 1,152 positions worth $33.6B, up 0.76% from $33.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Axa's Q2 2024 filing shows 97 new, 418 increased, 387 reduced and 96 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M. The largest sale was UnitedHealth, an estimated $101M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 721,967 shares worth $27.8M.
  • Axa added most to Advanced Micro Devices in Q2 2024, an estimated $94.4M increase.
  • Axa's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $101M.
  • Axa fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $46.4M.
  • Axa's ten largest holdings make up 29% of its $33.6B portfolio in Q2 2024.
  • Axa opened 97 new positions and closed 96 in Q2 2024.
  • Axa's portfolio value rose 0.76% quarter-over-quarter to $33.6B.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.